Home Health Costs Topics

Health Costs

Hospital Finances

Key Takeaways from CMS’s Rural Health Funding Announcement

This brief describes key takeaways from CMS's Notice of Funding Opportunity for the $50 billion Rural Health Transformation Program. It includes information about how CMS intends to review state applications and distribute funds and questions about the impact on rural hospitals, the distribution of funds across rural hospitals and states, and issues related to oversight and transparency.

10 Things to Know About Rural Hospitals

Key Facts About Hospitals: A Chart Collection

What are the Implications of the 2025 Budget Reconciliation Bill for Hospitals?

1 or 2 Health Systems Controlled the Entire Market for Inpatient Care in Nearly Half of Metro Areas

health system tracker
KEY RESOURCES

  • Health Policy 101: Costs and Affordability

    This Health Policy 101 chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies and the impact on affordability and people's overall financial vulnerability.  


  • Americans’ Challenges with Health Care Costs

    This data note reviews our recent polling data that finds that Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.

  • National Health Spending Explorer

    This interactive Peterson-KFF Health System Tracker tool allows users to examine five decades worth of data on health expenditures by federal and local governments, private insurers, and individuals.

  • Polling on Prescription Drugs and Their Prices

    This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Health Costs

Filter

List Grid

1,281 - 1,290 of 1,517 Results

  • Health Care Costs as Much as a New Car

    From Drew Altman

    Health care for a family covered by a large employer cost, on average, $22,885 last year. That’s $2,000 more than the sticker price for a brand-new Volkswagen Beetle. Drew Altman discusses why it matters in this Axios column.

  • How Many Medicare Part D Enrollees Had High Out-of-Pocket Drug Costs in 2017?

    Issue Brief

    The Medicare Part D prescription drug benefit has helped improve the affordability of medications for people with Medicare. Yet Part D enrollees can face relatively high out-of-pocket costs because the Part D benefit does not have a hard cap on out-of-pocket spending. This analysis presents the latest data on out-of-pocket drug spending among Medicare Part D enrollees without low-income subsidies who have costs above the catastrophic coverage threshold.

  • The Only Health Care Prices That Matter to Consumers

    From Drew Altman

    In this column, Drew Altman zeroes in on a key test for when the implementing rules are written for the new executive order on hospital price transparency: consumers will need to know what amount they must pay out of pocket to really help them shop on price.

  • Surprise Bills Often Hit in Emergencies

    From Drew Altman

    In an Axios column, Drew Altman previews new data highlighting that people with critical health issues are especially vulnerable to these bills. 

  • Private Insurance’s Costs are Skyrocketing

    From Drew Altman

    In this Axios column, Drew Altman takes a long-term view of the recently released federal data on health spending showing that spending for private insurance is rising much faster than for Medicare and Medicaid, and predicts rising pressure in the health care industry as a result. 

  • Quick Look: Antiretroviral Price Increases in Medicare Part D

    Issue Brief

    Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the federal government if prices increase faster than inflation. We assessed list price changes for ARVs under Part D, which is required to cover all or substantially all ARVs.